Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 241 - 250 of 997

The Role of Low-Threshold Treatment for Patients with Opioid Use Dusirder (OUD) in Primary Care

This Topic Brief provides an overview of what constitutes low-threshold treatment for patients with OUD, the state of the evidence and patient perspectives on low-threshold OUD treatment, and key steps and strategies for providing low-threshold treatment for patients with OUD in primary care settings.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Agency of Healthcare Quality and Research (AHRQ) Integration Academy
Year
Resource Type
Web Page

TIP 65: Counseling Approaches To Promote Recovery From Problematic Substance Use and Related Issues (PDF - 5.06 MB)

This treatment improvement protocol (TIP) provides guidance to counselors, administrators, and supervisors about recovery-oriented services, supports, and care, allowing them to better serve individuals in or seeking recovery from problematic substance use.
Format
Guide
Audience
Behavioral Health Providers
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF

Updated DEA Registration Certificate after Removal of X-Waiver (PDF - 92.4 KB)

This guidance document provides information regarding issuance of updated DEA registration certificates to reflect Congress’s elimination of the X-waiver (DATA-Waiver) in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Drug Enforcement Administration (DEA)
Year
Resource Type
PDF

Variation Across States in Loss of Medicaid Coverage Among Pregnant Beneficiaries with Substance Use Disorders (PDF - 657 KB)

Using a national Medicaid claims database, this brief estimates the number of pregnant beneficiaries with substance use disorder who lost Medicaid coverage 60 days postpartum at the national and state-level.
Format
Report/Paper/Issue Brief
Audience
States
Policymakers and Payers
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Assistant Secretary for Planning and Evaluation (ASPE)
Year
Resource Type
PDF

Waiver Elimination (MAT Act)

This web page provides frequently asked questions regarding the 2023 Consolidated Appropriations Act, which eliminates the X-waiver (DATA-Waiver) and increases accessibility of medication-assisted treatment (MAT).
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page

What are Opioids?

This fact sheet includes a basic description of opioids, a brief explanation of the risks, ways to prevent misuse, and strategies to helped loved ones who may be struggling with substance use disorder.
Format
Fact Sheet/Brochure
Audience
Patients
Families
Communities
Schools
Source
Partnership to End Addiction
Year
Resource Type
Web Page

What are Stimulants?

This fact sheet includes a basic description of stimulants, a brief explanation of the risks, ways to prevent misuse, and strategies to helped loved ones who may be struggling with substance use disorder.
Format
Fact Sheet/Brochure
Audience
Patients
Families
Communities
Schools
Source
Partnership to End Addiction
Year
Resource Type
Web Page

What is a DTx?

This page provides an overview on Digital therapeutics, which deliver patients evidence-based therapeutic interventions that are driven by high quality software programs to treat, manage, or prevent a disease or disorder. 
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Digital Therapeutics Alliance (DTA)
Year
Resource Type
Web Page